MTD, Safety and Efficacy of NYH817G and NYH100P in Monotherapy and Combination in Patients With Advanced Solid Tumors
Clinical trial NCT04262739 · UNKNOWN
Trial details
- NCT number
- NCT04262739
- Sponsor
- Haim Bio Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-18
- Primary completion
- 2021-12-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.